Fly News Breaks for June 27, 2019
Jun 27, 2019 | 05:48 EDT
Jefferies analyst Raj Denhoy raised his price target for Boston Scientific to $48 from $44 saying the company's investor meeting "was another positive look at a story that has been in sharp ascendancy for the last five years." The low end of the company's targeted growth rate of 6%-9% for 2020-2022 looks conservative given the stability in its mature markets and a "slew of new products" over the next few quarters, Denhoy tells investors in a research note. He keeps a Buy rating on the shares.
News For BSX From the Last 2 Days
There are no results for your query BSX